The Leaf THE LEAF January-February 2018 | Page 5

The study concludes that, “The experience of parents and patients with medicinal cannabis (CBD), as reported in our survey, suggests that CBD reduced the frequency, intensity, and duration of convulsive crises secondary to TSC.” This isn’t the first time CBD oil has been proven to reduce seizures. A 2017 study by Dr. Saul Garza Morales, paediatric researcher and neurologist in Mexico, found that 86 percent of the 29 child patients with extreme epilepsy experienced statistically significant (greater than 50%) reduction in motor seizures. Seventeen percent of the children were fully seizure free for a four-month period. Nearly half of cannabidiol patients stop using traditional medicines according to a recent report on CBD oil user experience by Brightfield Group and HelloMD, “Each time new study results are published showing the positive effects of CBD on a new indication is a victory for showcasing the therapeutic benefits of CBD and people around the world suffering from a multitude of debilitating conditions,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. Mexico legalised the cultivation, production, and u se of cannabis products with less than one percent THC for medical use when President Pena Nieto signed a bill into law on June 19. https://www.cashinbis.com/hempmeds-mexico- tuberous-sclerosis-complex-cbd-hemp-oil/